Dear Shareholders,
The year ending 30 June 2004 has been a very successful one for your Company, and we
are pleased to provide herewith the UXC Limited Preliminary Final Report.
In a year of many highlights, some of the more notable include the following:
• Revenue of $189.07 million,
up 63.9%
Revenue has grown significantly due to a
combination of organic growth and the impact
of acquisitions.
• EBITDA of $18.738 million,
up 108%
Earnings before interest, taxation, depreciation
and amortization has grown dramatically,
evidencing the robust performance of UXC
Business Units.
• PBT of $11.776 million,
up 76%
Profit before tax has grown substantially, after
absorbing a 112% increase in depreciation
and amortization, to $6.937 million, and a
$1 million reduction in net interest income.
These fluctuations reflect the investments being
made by UXC in operating businesses.
• NPAT of $9.015 million,
up 35%
Income tax expense increased by $2.724
million from the prior year.
• Research & Development costs
expensed
All research and development costs incurred in
operating divisions have been expensed in the
P&L in the period in which incurred.
• Contracts in hand of $124 million UXC has substantial annuity income,
representing 65% of FY2004 revenue. Of this,
$51 million extends beyond 12 months, and
$23 million is subject to annual renewal.
• Cash and Investments of
$16.868 million
Investments have good capital gain potential,
but did not contribute to earnings during the
period.
• Goodwill amortization of
$3.214 million, up 174%
Goodwill amortization has risen as a result of
the acquisition program. Underlying earnings
were robust enough to amply cover this cost
increase, the accounting treatment of which
will change under IFRS from FY2006.
Add to My Watchlist
What is My Watchlist?